Q1 adj. EBITA SEK 217m (-6% vs. ABGSCe, -4% vs. cons) Cons EBITA likely down 1%, but PTP et income d...
Q1e: We expect SEK 35.5m revenue and 11.4m EBIT '23e-'25e sales reduced by 3-7% on lowered FX and cu...
Share issue expected to lead to a more stable company Brand, technology and underlying market remain...
Sales down 35% y-o-y in Q1 EBIT likely negative as a result Both business areas affected Worrying t...
Redeye endorses today’s news that Herantis has signed the grant agreement with the European Innovati...
Wyld, har efter lansering av dess satellit-IoT-nätverkstjänst erhållit en kraftigt växande orderbok.
Analyst Group has entered into an agreement with Movinn on commissioned research, including Equity R...
Redeye updates its estimates following the ground-breaking news of the establishment of a Joint Vent...
Redeye comments on the outcome of Heliospectra's rights issue, which received a subscription rate of...
(Rättelsen är ett förtydligande om att det handlar om åtta europeiska länder, ej kliniker) Rapportko...
With a prolonged Russian cut-off from Europe, Russia’s energy war against the natural gas-dependent ...
In line with its ambitious growth plan, Agtira is now expanding its engagement with grocery producer...
Redeye updates its estimates ahead of the Q1 report (due 11 May) with slight downward adjustments, m...
Redeye comments on ISAB’s rights issue announcement of approximately SEK17.
Interimanalys stundar Under april kommer Guard att presentera resultat från en interimanalys från de...
Ett område som står inför en accelererande tillväxt Vi har tittat närmare på Mentice exponering mot ...
Redeye comments on Acarix following the near-term announcement of two uplifting press releases, incl...
Endomines reported strong production figures for Pampalo as the production increased 215% y/y during...
Biosergen, som utvecklar ett läkemedel för behandling av invasiva svampsjukdomar, har framgångsrikt ...
Idag den 4 april 2023 släppte Abelco bolagets kvartalsredogörelse för Q1-23 och givet att vår senast...
